Clinical Trial Evidence and Findings in Female Participants Phase 2 trial data (Jastreboff et al., NEJM, 2023) showed dose-dependent weight reduction and metabolic improvements, but sex-disaggregated results were not published, so female-specific efficacy cannot yet be confirmed
At Southern Urogynecology Wellness and Aesthetics, we understand the reality of these struggles, and were here to offer a different kind of support
Its long establishment and active review presence contribute to its reputation as a well-known UK peptide supplier
When used under medical supervision, tirzepatide not only supports weight lossit can also help reduce inflammation, improve metabolic health, and lower your risk of weight-related conditions like high blood pressure, insulin resistance, and cardiovascular disease
The challenge with upper arm self-injection is access